Exploring the Use of mRNA-LNP for Antigen-Specific Immune Tolerance
Time: 9:00 am
day: Conference Day Two
Details:
- Focusing on the mRNA and LNP to identify an optimal drug product for inducing antigen-specific tolerance
- Highlighting the influence of the antigen on T-cell fate outcomes
- Interrogating what target product profile may be achievable
